Evidence map›Paper›PMID 23812967›Full record

ReviewCurrent urology reports2013

Understanding clinic options for overactive bladder.

Jamie M Bartley, Emily S Blum, Larry T Sirls, Kenneth M Peters

Abstract readReview
PubMed Publisher
In one paragraph

Review in Current urology reports, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
3.8field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Electroanatomical Mapping of the Urinary Bladder.International neurourology journal · 2016
    Article
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Jamie M BartleyWilliam Beaumont Hospital Women's Urology Center, 3601 West 13 Mile Road, 2-South, Royal Oak, MI, 48073, USA, Jamie.Bartley@beaumont.edu.
Emily S Blum
Larry T Sirls
Kenneth M Peters
Beaumont Hospital, Royal Oak · USBeaumont Hospital, Troy · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Overactive bladder (OAB) is a symptom complex of urinary frequency, nocturia and urgency with or without urgency incontinence that adversely impacts patient's quality of life. Conservative management begins in the outpatient clinic, often with significant improvement and patient satisfaction. In this review we will discuss the evaluation of OAB and review treatment options focusing on behavioral modification, medical therapy, and neuromodulation. These treatment options are offered in a stepwise fashion, remembering that more than one may be needed and can be used concomitantly.

Indexed as

Behavior TherapyElectric Stimulation TherapyAdrenergic beta-3 Receptor AgonistsAmbulatory CareBotulinum Toxins, Type AHumansImplantable NeurostimulatorsMuscarinic AntagonistsNeuromuscular AgentsPatient Education as TopicUrinary Bladder, OveractiveAdrenergic beta-3 Receptor AgonistsBotulinum Toxins, Type AMuscarinic AntagonistsNeuromuscular Agents

Identifiers

PMID23812967
OpenAlexW1984022426

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.